Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort. [PDF]
Valentini S +14 more
europepmc +1 more source
Vaccination Against Herpes Zoster in Adults: Current Strategies in European Union Countries. [PDF]
Chiavarini M +6 more
europepmc +1 more source
BC02-adjuvanted varicella-zoster virus glycoprotein E subunit vaccine overcomes immunosenescence to induce robust neutralizing antibodies and multifunctional T-cell immunity in seropositive aged murine models. [PDF]
Li J +10 more
europepmc +1 more source
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients [PDF]
Carpenter, B +6 more
core +1 more source
Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care. [PDF]
Fabris C +7 more
europepmc +1 more source
A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK. [PDF]
Beillat, Maud +4 more
core +1 more source
Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. [PDF]
Rayens E +16 more
europepmc +1 more source
Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial. [PDF]
Kim TH +10 more
europepmc +1 more source

